Logo image of AVAH

AVEANNA HEALTHCARE HOLDINGS (AVAH) Stock Fundamental Analysis

NASDAQ:AVAH - Nasdaq - US05356F1057 - Common Stock - Currency: USD

3.85  +0.04 (+1.05%)

After market: 3.85 0 (0%)

Fundamental Rating

2

AVAH gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 107 industry peers in the Health Care Providers & Services industry. AVAH may be in some trouble as it scores bad on both profitability and health. AVAH is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

AVAH had negative earnings in the past year.
In the past year AVAH had a positive cash flow from operations.
In the past 5 years AVAH always reported negative net income.
In multiple years AVAH reported negative operating cash flow during the last 5 years.
AVAH Yearly Net Income VS EBIT VS OCF VS FCFAVAH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 0 -200M -400M -600M

1.2 Ratios

AVAH has a Return On Assets of -4.00%. This is in the lower half of the industry: AVAH underperforms 62.04% of its industry peers.
The Return On Invested Capital of AVAH (7.88%) is better than 75.00% of its industry peers.
AVAH had an Average Return On Invested Capital over the past 3 years of 4.24%. This is below the industry average of 8.16%.
The 3 year average ROIC (4.24%) for AVAH is below the current ROIC(7.88%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -4%
ROE N/A
ROIC 7.88%
ROA(3y)-17.34%
ROA(5y)-11.99%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)4.24%
ROIC(5y)4.05%
AVAH Yearly ROA, ROE, ROICAVAH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 0 5K 10K 15K

1.3 Margins

AVAH has a better Operating Margin (6.22%) than 67.59% of its industry peers.
AVAH's Operating Margin has improved in the last couple of years.
AVAH's Gross Margin of 30.87% is in line compared to the rest of the industry. AVAH outperforms 56.48% of its industry peers.
In the last couple of years the Gross Margin of AVAH has remained more or less at the same level.
Industry RankSector Rank
OM 6.22%
PM (TTM) N/A
GM 30.87%
OM growth 3Y3.11%
OM growth 5Y6.61%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.1%
GM growth 5Y-0.02%
AVAH Yearly Profit, Operating, Gross MarginsAVAH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 0 20 -20

More info and screens

0

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), AVAH is destroying value.
The number of shares outstanding for AVAH has been increased compared to 1 year ago.
Compared to 1 year ago, AVAH has a worse debt to assets ratio.
AVAH Yearly Shares OutstandingAVAH Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 50M 100M 150M
AVAH Yearly Total Debt VS Total AssetsAVAH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 500M 1B 1.5B 2B

2.2 Solvency

Based on the Altman-Z score of 0.48, we must say that AVAH is in the distress zone and has some risk of bankruptcy.
AVAH has a worse Altman-Z score (0.48) than 70.37% of its industry peers.
The Debt to FCF ratio of AVAH is 147.39, which is on the high side as it means it would take AVAH, 147.39 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of AVAH (147.39) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 147.39
Altman-Z 0.48
ROIC/WACC0.79
WACC9.92%
AVAH Yearly LT Debt VS Equity VS FCFAVAH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 500M 1B

2.3 Liquidity

AVAH has a Current Ratio of 0.94. This is a bad value and indicates that AVAH is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.94, AVAH is not doing good in the industry: 77.78% of the companies in the same industry are doing better.
AVAH has a Quick Ratio of 0.94. This is a bad value and indicates that AVAH is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.94, AVAH is doing worse than 73.15% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.94
Quick Ratio 0.94
AVAH Yearly Current Assets VS Current LiabilitesAVAH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 100M 200M 300M

More info and screens

4

3. Growth

3.1 Past

AVAH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 84.62%, which is quite impressive.
Looking at the last year, AVAH shows a small growth in Revenue. The Revenue has grown by 6.22% in the last year.
AVAH shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.62% yearly.
EPS 1Y (TTM)84.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%166.67%
Revenue 1Y (TTM)6.22%
Revenue growth 3Y8.23%
Revenue growth 5Y8.62%
Sales Q2Q%6.49%

3.2 Future

AVAH is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 43.96% yearly.
The Revenue is expected to grow by 5.61% on average over the next years.
EPS Next Y106.37%
EPS Next 2Y62.73%
EPS Next 3Y48.32%
EPS Next 5Y43.96%
Revenue Next Year6.51%
Revenue Next 2Y5.8%
Revenue Next 3Y5.57%
Revenue Next 5Y5.61%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
AVAH Yearly Revenue VS EstimatesAVAH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B
AVAH Yearly EPS VS EstimatesAVAH Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.1 -0.1 0.2 0.3 0.4

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AVAH. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 49.50 indicates a quite expensive valuation of AVAH.
AVAH's Price/Forward Earnings ratio is in line with the industry average.
When comparing the Price/Forward Earnings ratio of AVAH to the average of the S&P500 Index (22.10), we can say AVAH is valued expensively.
Industry RankSector Rank
PE N/A
Fwd PE 49.5
AVAH Price Earnings VS Forward Price EarningsAVAH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50 -100 -150

4.2 Price Multiples

AVAH's Enterprise Value to EBITDA ratio is in line with the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of AVAH is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 75.4
EV/EBITDA 14.07
AVAH Per share dataAVAH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as AVAH's earnings are expected to grow with 48.32% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y62.73%
EPS Next 3Y48.32%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for AVAH!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AVEANNA HEALTHCARE HOLDINGS

NASDAQ:AVAH (3/7/2025, 8:06:14 PM)

After market: 3.85 0 (0%)

3.85

+0.04 (+1.05%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-07 2024-11-07/bmo
Earnings (Next)03-13 2025-03-13/bmo
Inst Owners43.67%
Inst Owner Change-0.27%
Ins Owners5.91%
Ins Owner Change5.97%
Market Cap743.94M
Analysts50.77
Price Target5.38 (39.74%)
Short Float %1.42%
Short Ratio6.38
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)202.94%
Min EPS beat(2)149.02%
Max EPS beat(2)256.86%
EPS beat(4)4
Avg EPS beat(4)115.35%
Min EPS beat(4)17.44%
Max EPS beat(4)256.86%
EPS beat(8)6
Avg EPS beat(8)54.97%
EPS beat(12)6
Avg EPS beat(12)13.27%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)0.48%
Min Revenue beat(2)0.34%
Max Revenue beat(2)0.61%
Revenue beat(4)3
Avg Revenue beat(4)0.2%
Min Revenue beat(4)-0.61%
Max Revenue beat(4)0.61%
Revenue beat(8)6
Avg Revenue beat(8)0.63%
Revenue beat(12)7
Avg Revenue beat(12)-0.44%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-3.14%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)-100%
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.15%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.05%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 49.5
P/S 0.38
P/FCF 75.4
P/OCF 45.86
P/B N/A
P/tB N/A
EV/EBITDA 14.07
EPS(TTM)-0.02
EYN/A
EPS(NY)0.08
Fwd EY2.02%
FCF(TTM)0.05
FCFY1.33%
OCF(TTM)0.08
OCFY2.18%
SpS10.26
BVpS-0.8
TBVpS-6.72
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4%
ROE N/A
ROCE 9.97%
ROIC 7.88%
ROICexc 8.41%
ROICexgc 634.57%
OM 6.22%
PM (TTM) N/A
GM 30.87%
FCFM 0.5%
ROA(3y)-17.34%
ROA(5y)-11.99%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)4.24%
ROIC(5y)4.05%
ROICexc(3y)4.36%
ROICexc(5y)4.2%
ROICexgc(3y)138.9%
ROICexgc(5y)112.76%
ROCE(3y)5.39%
ROCE(5y)5.14%
ROICexcg growth 3Y5.69%
ROICexcg growth 5YN/A
ROICexc growth 3Y18.24%
ROICexc growth 5YN/A
OM growth 3Y3.11%
OM growth 5Y6.61%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.1%
GM growth 5Y-0.02%
F-Score6
Asset Turnover1.21
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 147.39
Debt/EBITDA 8.46
Cap/Depr 23.33%
Cap/Sales 0.32%
Interest Coverage 0.8
Cash Conversion 10.76%
Profit Quality N/A
Current Ratio 0.94
Quick Ratio 0.94
Altman-Z 0.48
F-Score6
WACC9.92%
ROIC/WACC0.79
Cap/Depr(3y)51.44%
Cap/Depr(5y)71.96%
Cap/Sales(3y)0.65%
Cap/Sales(5y)0.83%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)84.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%166.67%
EPS Next Y106.37%
EPS Next 2Y62.73%
EPS Next 3Y48.32%
EPS Next 5Y43.96%
Revenue 1Y (TTM)6.22%
Revenue growth 3Y8.23%
Revenue growth 5Y8.62%
Sales Q2Q%6.49%
Revenue Next Year6.51%
Revenue Next 2Y5.8%
Revenue Next 3Y5.57%
Revenue Next 5Y5.61%
EBIT growth 1Y45.08%
EBIT growth 3Y11.59%
EBIT growth 5Y15.8%
EBIT Next Year38.27%
EBIT Next 3Y16.78%
EBIT Next 5Y15.03%
FCF growth 1Y117.57%
FCF growth 3Y-45.34%
FCF growth 5Y52.61%
OCF growth 1Y138.9%
OCF growth 3Y-42.07%
OCF growth 5Y0.97%